Home » Topics » Disease categories and therapies » Infection

Infection
RSS

CS-834: a new oral carbapenem in active development at Sankyo

Oct. 17, 1997

BIRR-4: a new cold remedy on the horizon?

Oct. 17, 1997

Peptide drugs for treating leishmaniasis

Oct. 17, 1997

Antiinfective and immunomodulatory micacocidin derivatives from Shionogi

Oct. 17, 1997

Sequence of S. epidermidis revealed

Oct. 17, 1997

Ortho describes bacterial HPK inhibitors as antibacterial agents

Oct. 16, 1997

KRM-1648: a rifamycin derivative active against H. pylori and Mycobacterium spp.

Oct. 15, 1997

Echinocandin antifungal agent tested in patients

Oct. 15, 1997

Natural compound for combatting fungal infections disclosed

Oct. 15, 1997

Millennium reaches milestones in discovery of antibacterial drug targets

Oct. 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...